Dividend Details

INDOCO REMEDIES LTD.

NSE : INDOCOBSE : 532612ISIN CODE : INE873D01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE328.50-6.05 (-1.81 %)
PREV CLOSE ( ) 334.55
OPEN PRICE ( ) 335.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6666
TODAY'S LOW / HIGH ( )327.00 338.25
52 WK LOW / HIGH ( )307 416.95
NSE328.65-5.25 (-1.57 %)
PREV CLOSE( ) 333.90
OPEN PRICE ( ) 337.85
BID PRICE (QTY) 328.65 (268)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 75404
TODAY'S LOW / HIGH( ) 327.45 338.80
52 WK LOW / HIGH ( )306.4 415

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.